Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Environmental Research
Climate Change-Related Disturbances Linked to Worse Cardiovascular Health, Researchers Show
06/13/2024

Beth Israel Deaconess Medical Center (BIDMC) News

Beth Israel Deaconess Medical Center ...
“Climate change is already affecting our cardiovascular health; exposure to extreme heat can adversely affect heart rate and blood pressure; exposure to ozone or wildfire smog can trigger systemic inflammation; living through a natural...
“Climate change is already affecting our cardiovascular health; exposure to extreme heat can adversely affect heart rate and blood pressure; exposure to ozone or wildfire smog can trigger systemic inflammation; living through a natural...
“Climate change is already...
06/13/2024
Cath Lab Digest
Duo Venous Stent System (Royal Philips)
Venous Intervention
Philips Launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction
06/12/2024

Royal Philips News

Royal Philips News
Royal Philips announced the first implant of the Duo Venous Stent System, an implantable medical device indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket...
Royal Philips announced the first implant of the Duo Venous Stent System, an implantable medical device indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket...
Royal Philips announced the...
06/12/2024
Cath Lab Digest

Advertisement

MiRus Siegel TAVR
Transcatheter Heart Valves
MiRus Siegel TAVR: First in Human Results Presented at New York Valves
06/12/2024

MiRus News

MiRus News
The Siegel valve represents several firsts in TAVR: 8 French delivery sheath allowing less invasive procedures and broader patient access, particularly for women; the only nickel-free THV allowing treatment of the 20% of Americans suffering...
The Siegel valve represents several firsts in TAVR: 8 French delivery sheath allowing less invasive procedures and broader patient access, particularly for women; the only nickel-free THV allowing treatment of the 20% of Americans suffering...
The Siegel valve represents...
06/12/2024
Cath Lab Digest
News
CIS and BRG are First in Louisiana to Use New Generation Diamondback 360 Precision™ Orbital Atherectomy System
06/12/2024

CIS Press Release

CIS Press Release
BATON ROUGE, LA – Dr. Garland Green, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the new generation Diamondback 360 Precision™ Orbital Atherectomy System (OAS) to treat coronary...
BATON ROUGE, LA – Dr. Garland Green, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Louisiana to use the new generation Diamondback 360 Precision™ Orbital Atherectomy System (OAS) to treat coronary...
BATON ROUGE, LA – Dr. Garland...
06/12/2024
Vascular Disease Management
News
CIS & Terrebonne General are First in Louisiana to Implant Medtronic’s Evolut FX+ Valve
06/11/2024
HOUMA, LA— Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to treat a patient using the new FDA-approved Evolut™ FX+ transcatheter aortic valve replacement...
HOUMA, LA— Cardiovascular Institute of the South (CIS) and Terrebonne General Health System (Terrebonne General) are the first in Louisiana to treat a patient using the new FDA-approved Evolut™ FX+ transcatheter aortic valve replacement...
HOUMA, LA— Cardiovascular...
06/11/2024
Vascular Disease Management

Advertisement

Transcatheter Heart Valves
Anteris Provides Data Update on First-in-Human Study of DurAVR THV Presented at New York Valves 2024
06/11/2024

Anteris Technologies, Ltd., News

Anteris Technologies, Ltd., News ...
Anteris Technologies Ltd, a structural heart company developing DurAVR THV, a balloon-expandable, single-piece biomimetic aortic replacement valve shaped to mimic the native human valve, announced a summation of the Company’s presentation at...
Anteris Technologies Ltd, a structural heart company developing DurAVR THV, a balloon-expandable, single-piece biomimetic aortic replacement valve shaped to mimic the native human valve, announced a summation of the Company’s presentation at...
Anteris Technologies Ltd, a...
06/11/2024
Cath Lab Digest
mental health
Laxmi Mehta, MD, Chairs American Heart Association Advisory on Psychological Stress: Advisory Details Ways for Organizations to Support Mental Health of Cardiovascular Healthcare Employees
06/11/2024

The Ohio State University Wexner Medical Center News

The Ohio State University Wexner Medi...
“There are many stressors in cardiovascular medicine, including an aging cardiovascular patient population and workforce, and a decrease in cardiologists entering the field because of insufficient fellowship positions despite the rising...
“There are many stressors in cardiovascular medicine, including an aging cardiovascular patient population and workforce, and a decrease in cardiologists entering the field because of insufficient fellowship positions despite the rising...
“There are many stressors in...
06/11/2024
Cath Lab Digest
reperfusion injury
Faraday Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 Iocyte AMI-3 Trial of FDY-5301
06/11/2024

Faraday Pharmaceuticals, Inc., News

Faraday Pharmaceuticals, Inc., News ...
The Iocyte AMI-3 trial is a randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of FDY-5301 in reducing cardiovascular death and heart failure events in anterior STEMI patients undergoing PCI.
The Iocyte AMI-3 trial is a randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of FDY-5301 in reducing cardiovascular death and heart failure events in anterior STEMI patients undergoing PCI.
The Iocyte AMI-3 trial is a...
06/11/2024
Cath Lab Digest

Advertisement

Environment
Passive Heat Exposure Increases Stress on Heart, Posing Risk to Adults With History of CAD
06/11/2024

American College of Physicians News

American College of Physicians News ...
Passive heat exposure was enough to increase myocardial blood flow in all participants, regardless of age and health status, creating significant stress on the heart. The authors observed asymptomatic heat-induced myocardial ischemia in some...
Passive heat exposure was enough to increase myocardial blood flow in all participants, regardless of age and health status, creating significant stress on the heart. The authors observed asymptomatic heat-induced myocardial ischemia in some...
Passive heat exposure was enough...
06/11/2024
Cath Lab Digest
Nutrition
Beetroot Juice Promotes Healthy Circulation in Postmenopausal Women, According to Study Led by Penn State Researchers
06/10/2024

Penn State News

Penn State News
“Some clinicians are already recommending beetroot juice to men and women with high blood pressure,” Jocelyn Delgado Spicuzza said. “By providing a safe and effective way to improve blood vessel function, beets could help maintain...
“Some clinicians are already recommending beetroot juice to men and women with high blood pressure,” Jocelyn Delgado Spicuzza said. “By providing a safe and effective way to improve blood vessel function, beets could help maintain...
“Some clinicians are already...
06/10/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

News

DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest
acute mI
CLEAR SYNERGY (OASIS 9) Trial @TCT: Routine Colchicine Administration After Acute Myocardial Infarction Does Not Improve Outcomes
10/30/2024
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication...
10/30/2024
Cath Lab Digest
Intravascular Lithotripsy
Data From Elixir’s PINNACLE I Trial for Calcium Fragmentation in Calcified Coronary Artery Lesions Presented at TCT
10/30/2024
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging...
10/30/2024
Cath Lab Digest
Tricuspid Valve Treatment
TCT: TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-Life Benefits With Edwards Evoque System for Severe Tricuspid Regurgitation
10/30/2024
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized...
10/30/2024
Cath Lab Digest
Post MI
After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing
10/30/2024
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in...
10/30/2024
Cath Lab Digest
Bioadaptors
TCT: DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months
10/29/2024
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant...
10/29/2024
Cath Lab Digest
Aortic Stenosis
TCT: Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR)
10/29/2024
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from...
10/29/2024
Cath Lab Digest
Zilver Vena Stent
Zilver Vena Stent Shows High Patency Across All Patient Groups in Three-Year Clinical Study
10/29/2024
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook...
10/29/2024
Vascular Disease Management
Coronary Atherectomy
TCT: Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, ECLIPSE Study Finds
10/29/2024
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy...
10/29/2024
Cath Lab Digest
Large Bore Closure
TCT: Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal Large Hole Closure Device
10/29/2024
The Vivasure PerQseal® Closure Device System (PerQSeal) is the first sutureless, fully absorbable synthetic implement for large-bore vessel punctures, and is an alternative to the use of suture- or collagen-based closure devices.
The Vivasure PerQseal® Closure Device System (PerQSeal) is the first sutureless, fully absorbable synthetic implement for large-bore vessel punctures, and is an alternative to the use of suture- or collagen-based closure devices.
The Vivasure PerQseal® Closure...
10/29/2024
Cath Lab Digest

Advertisement

Advertisement

TAVR
TAVR UNLOAD @TCT: Transcatheter Aortic Valve Replacement in Patients with Systolic Heart Failure and Moderate Aortic Stenosis Shows Limited Benefits
10/30/2024
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).
Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).
Findings from the TAVR UNLOAD...
10/30/2024
Cath Lab Digest
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest
acute mI
CLEAR SYNERGY (OASIS 9) Trial @TCT: Routine Colchicine Administration After Acute Myocardial Infarction Does Not Improve Outcomes
10/30/2024
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication that reduces inflammation and smaller studies have indicated potential benefits for cardiovascular patients.
Colchicine is an oral medication...
10/30/2024
Cath Lab Digest
Intravascular Lithotripsy
Data From Elixir’s PINNACLE I Trial for Calcium Fragmentation in Calcified Coronary Artery Lesions Presented at TCT
10/30/2024
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging sub-study using optical coherence tomography (OCT) was conducted to accurately assess lesion complexity and calcium fragmentation effectiveness of LithiX IVL across a range of complex calcium morphologies.
An intravascular imaging...
10/30/2024
Cath Lab Digest
Tricuspid Valve Treatment
TCT: TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-Life Benefits With Edwards Evoque System for Severe Tricuspid Regurgitation
10/30/2024
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized controlled pivotal trial designed to study the Evoque transcatheter tricuspid valve replacement (TTVR) system with optimal medical therapy (OMT) compared to OMT alone with 2:1 randomization.
TRISCEND II is a randomized...
10/30/2024
Cath Lab Digest
Post MI
After a Heart Attack, the Heart Signals to the Brain to Increase Sleep to Promote Healing
10/30/2024
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in Nature, emphasize the importance of increased sleep after a heart attack, and suggest that sufficient sleep should be a focus of post-heart-attack clinical management and care, including in the intensive care...
The novel findings, published in...
10/30/2024
Cath Lab Digest
Bioadaptors
TCT: DynamX Bioadaptor Demonstrates Significant Improvement Over Contemporary Drug-Eluting Stent in Patients with Acute Coronary Syndrome and Complex Lesion Subsets After Six Months
10/29/2024
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant benefit of the DynamX® Coronary Bioadaptor System compared to a contemporary zotarolimus drug-eluting stent for target lesion failure in complex patient population subsets from the INFINITY-SWEDEHEART RCT.
Data demonstrate significant...
10/29/2024
Cath Lab Digest
Aortic Stenosis
TCT: Real-World Evidence Demonstrates Improved Survival in Asymptomatic Aortic Stenosis Patients Undergoing Aortic Valve Replacement (AVR)
10/29/2024
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from over 2 million patients in a real-world database of 29 teaching and non-teaching U.S. health systems.
The study analyzed data from...
10/29/2024
Cath Lab Digest
Zilver Vena Stent
Zilver Vena Stent Shows High Patency Across All Patient Groups in Three-Year Clinical Study
10/29/2024
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook Medical’s Zilver Vena® Venous Self-Expanding Stent has shown high rates of patency sustained for three years, according to recently published data in the Journal of Vascular and Interventional Radiology (JVIR).1 The...
Bloomington, Ind. — Cook...
10/29/2024
Vascular Disease Management
Coronary Atherectomy
TCT: Treating Severe Calcification With an Atherectomy Device Does Not Improve Cardiac Stenting Outcomes, ECLIPSE Study Finds
10/29/2024
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy may be reserved for the most extreme cases for which the operator does not believe that balloon angioplasty would be likely to safely cross or pre-dilate the calcified lesion,” said Gregg Stone, MD.
"The use of orbital atherectomy...
10/29/2024
Cath Lab Digest

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use